Responsiveness of gonadotropin secretion to infusion of an opiate-receptor antagonist in hypogonadotropic individuals

Johannes D Veldhuis, H. E. Kulin, B. A. Warner, S. J. Santner

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

We tested the hypothesis that suppressive effects of endogenous opiate substances are involved in certain hypogonadotropic states. For this purpose, we studied gonadotropin secretion in idiopathic hypopituitarism (5 children), constitutionally delayed adolescence (5 boys), and Kallmann's syndrome (3 men). Endogenous opiate pathways were antagonized by the iv infusion of naloxone hydrochloride at a dose previously shown to elicit a prompt and significant increase in serum levels of LH in normal men. Under these conditions, naloxone did not increase serially sampled serum concentrations or mean urinary levels of LH or FSH in 8 patients with idiopathic hypopituitarism or Kallmann's syndrome. Gonadotropin concentrations in 4 of 5 patients with constitutional delay of adolescence also were unaffected. In one boy with clinical and biochemical indices of late pubertal development, naloxone elicited a significant increase in LH levels in blood and urine, similar to the pattern observed in normal men. In contrast to results in experimental animals, naloxone did not suppress serum PRL concentration significantly in any subject. These observations suggest that: 1) endogenous opiate mechanisms are unlikely to constitute a principal factor in maintaining hypogonadotropism in idiopathic hypopituitarism, delayed adolescence, or Kallmann's syndrome, at least acutely; 2) endogenous opiate mechanisms also cannot be implicated in the acute regulation of PRL secretion in children; and 3) the capability of adult men, but not early pubertal boys, to respond with increased gonadotropin secretion during inhibition of opiate receptors suggests that maturation of the opiate-related neuroendocrine system occurs during the course of sexual development in the human.

Original languageEnglish (US)
Pages (from-to)649-653
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume55
Issue number4
StatePublished - 1982
Externally publishedYes

Fingerprint

Opioid Peptides
Opioid Receptors
Naloxone
Gonadotropins
Kallmann Syndrome
Hypopituitarism
Opiate Alkaloids
Serum
Animals
Blood
Neurosecretory Systems
Sexual Development
Urine

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Responsiveness of gonadotropin secretion to infusion of an opiate-receptor antagonist in hypogonadotropic individuals. / Veldhuis, Johannes D; Kulin, H. E.; Warner, B. A.; Santner, S. J.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 55, No. 4, 1982, p. 649-653.

Research output: Contribution to journalArticle

Veldhuis, Johannes D ; Kulin, H. E. ; Warner, B. A. ; Santner, S. J. / Responsiveness of gonadotropin secretion to infusion of an opiate-receptor antagonist in hypogonadotropic individuals. In: Journal of Clinical Endocrinology and Metabolism. 1982 ; Vol. 55, No. 4. pp. 649-653.
@article{e1d06641162d484cb819b2378d40fbb6,
title = "Responsiveness of gonadotropin secretion to infusion of an opiate-receptor antagonist in hypogonadotropic individuals",
abstract = "We tested the hypothesis that suppressive effects of endogenous opiate substances are involved in certain hypogonadotropic states. For this purpose, we studied gonadotropin secretion in idiopathic hypopituitarism (5 children), constitutionally delayed adolescence (5 boys), and Kallmann's syndrome (3 men). Endogenous opiate pathways were antagonized by the iv infusion of naloxone hydrochloride at a dose previously shown to elicit a prompt and significant increase in serum levels of LH in normal men. Under these conditions, naloxone did not increase serially sampled serum concentrations or mean urinary levels of LH or FSH in 8 patients with idiopathic hypopituitarism or Kallmann's syndrome. Gonadotropin concentrations in 4 of 5 patients with constitutional delay of adolescence also were unaffected. In one boy with clinical and biochemical indices of late pubertal development, naloxone elicited a significant increase in LH levels in blood and urine, similar to the pattern observed in normal men. In contrast to results in experimental animals, naloxone did not suppress serum PRL concentration significantly in any subject. These observations suggest that: 1) endogenous opiate mechanisms are unlikely to constitute a principal factor in maintaining hypogonadotropism in idiopathic hypopituitarism, delayed adolescence, or Kallmann's syndrome, at least acutely; 2) endogenous opiate mechanisms also cannot be implicated in the acute regulation of PRL secretion in children; and 3) the capability of adult men, but not early pubertal boys, to respond with increased gonadotropin secretion during inhibition of opiate receptors suggests that maturation of the opiate-related neuroendocrine system occurs during the course of sexual development in the human.",
author = "Veldhuis, {Johannes D} and Kulin, {H. E.} and Warner, {B. A.} and Santner, {S. J.}",
year = "1982",
language = "English (US)",
volume = "55",
pages = "649--653",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Responsiveness of gonadotropin secretion to infusion of an opiate-receptor antagonist in hypogonadotropic individuals

AU - Veldhuis, Johannes D

AU - Kulin, H. E.

AU - Warner, B. A.

AU - Santner, S. J.

PY - 1982

Y1 - 1982

N2 - We tested the hypothesis that suppressive effects of endogenous opiate substances are involved in certain hypogonadotropic states. For this purpose, we studied gonadotropin secretion in idiopathic hypopituitarism (5 children), constitutionally delayed adolescence (5 boys), and Kallmann's syndrome (3 men). Endogenous opiate pathways were antagonized by the iv infusion of naloxone hydrochloride at a dose previously shown to elicit a prompt and significant increase in serum levels of LH in normal men. Under these conditions, naloxone did not increase serially sampled serum concentrations or mean urinary levels of LH or FSH in 8 patients with idiopathic hypopituitarism or Kallmann's syndrome. Gonadotropin concentrations in 4 of 5 patients with constitutional delay of adolescence also were unaffected. In one boy with clinical and biochemical indices of late pubertal development, naloxone elicited a significant increase in LH levels in blood and urine, similar to the pattern observed in normal men. In contrast to results in experimental animals, naloxone did not suppress serum PRL concentration significantly in any subject. These observations suggest that: 1) endogenous opiate mechanisms are unlikely to constitute a principal factor in maintaining hypogonadotropism in idiopathic hypopituitarism, delayed adolescence, or Kallmann's syndrome, at least acutely; 2) endogenous opiate mechanisms also cannot be implicated in the acute regulation of PRL secretion in children; and 3) the capability of adult men, but not early pubertal boys, to respond with increased gonadotropin secretion during inhibition of opiate receptors suggests that maturation of the opiate-related neuroendocrine system occurs during the course of sexual development in the human.

AB - We tested the hypothesis that suppressive effects of endogenous opiate substances are involved in certain hypogonadotropic states. For this purpose, we studied gonadotropin secretion in idiopathic hypopituitarism (5 children), constitutionally delayed adolescence (5 boys), and Kallmann's syndrome (3 men). Endogenous opiate pathways were antagonized by the iv infusion of naloxone hydrochloride at a dose previously shown to elicit a prompt and significant increase in serum levels of LH in normal men. Under these conditions, naloxone did not increase serially sampled serum concentrations or mean urinary levels of LH or FSH in 8 patients with idiopathic hypopituitarism or Kallmann's syndrome. Gonadotropin concentrations in 4 of 5 patients with constitutional delay of adolescence also were unaffected. In one boy with clinical and biochemical indices of late pubertal development, naloxone elicited a significant increase in LH levels in blood and urine, similar to the pattern observed in normal men. In contrast to results in experimental animals, naloxone did not suppress serum PRL concentration significantly in any subject. These observations suggest that: 1) endogenous opiate mechanisms are unlikely to constitute a principal factor in maintaining hypogonadotropism in idiopathic hypopituitarism, delayed adolescence, or Kallmann's syndrome, at least acutely; 2) endogenous opiate mechanisms also cannot be implicated in the acute regulation of PRL secretion in children; and 3) the capability of adult men, but not early pubertal boys, to respond with increased gonadotropin secretion during inhibition of opiate receptors suggests that maturation of the opiate-related neuroendocrine system occurs during the course of sexual development in the human.

UR - http://www.scopus.com/inward/record.url?scp=0020427950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020427950&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 649

EP - 653

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -